$$$$ALQA Heating UP~

$ALQA Alliqua currently markets its new line of 510K FDA approved hydrogel products for wound care under the SilverSeal® brand.  The Company's electron beam production process located at its 16,000 square foot GMP manufacturing facility in Langhorne, PA, allows Alliqua to aggressively develop and custom manufacture a wide variety of hydrogels. Alliqua's hydrogels can be customized for various transdermal applications to address market opportunities in the treatment of wounds as well as the delivery of numerous drugs or other agents for the pharmaceutical and cosmetic industries.  Additionally, Alliqua's drug delivery platform, in combination with certain drugs, provides pharmaceutical companies with potential greater patient compliance and could potentially extend the life of valuable drug patents. Additionally, our subsidiary, HepaLife Biosystems, Inc., focuses on the development of a cell-based bioartificial liver system, known as HepaMate™.

$ALQA WOW!!!!

Same here GREGG, $$$$$ALQA~

Cool, thx~

I'm a fairly new shareholder myself. We all feel like this a very interesting time to be a part of this. It's almost like a brand new company except they have 510k FDA Approved products to market and sell. Lots of good developments over the past couple of weeks and expecting more soon.

ALQA
$$$$$$$$

$ALQA Welcome to the board Joe. GLTU if you are in ALQA...
We are all watching the company's development since the New CEO came on
board back in Oct. and how he has been assembling the BOD. Alliqua has
lots of potential.

ALQA
$$$$$$$$$$$

$ALQA In addition to his distinguished career in the pharmaceutical industry Dr. Zeldis has served as Professor of Clinical Medicine at the Robert Wood Johnson Medical School (July 1998 to June 2010), Clinical Associate Professor of Medicine at Cornell Medical School (January 1995 to December 2003), Associate Professor of Medicine at University of California, Davis (September 1988 to September 1994), and Assistant Professor of Medicine at the Harvard Medical School (July 1987 to September 1988).  Dr. Zeldis received a BA and an MS from Brown University, and an M Phil, an MD, and a PhD in Molecular Biophysics and Biochemistry from Yale University.

Dr. Zeldis stated "I am very pleased to chair the Board of Directors of Alliqua during this time of transition in which our platform technologies are being applied to wound care, dermal and transdermal delivery of pharmaceutical products, and the care of patients with end-stage liver disease. I am looking forward to help foster this development."

$ALQA I would love to see that

$ALQA It's all out in the open....

$ALQA Good observation. It's not just being handed to him.
Mostly Everyone is just hanging around seeing what they do...

$ ALQA ~ Yes, I agree....

All we need is patience now....
Very nice looking chart!

Bmak still on the bid with 5mil?

Bought my tickets weeks ago. Just waiting on the captain to take us to our destination....

That is the best part. Shouldnt be too long before we start closing in on that pps

Hey mornin Kaiser...
Lets see what the week has in store for us.

$ ALQA ~ That's Right Kaiser...

 
$$$ALQA Huge Potential Billion Dollar future opportunity:
Their proprietary technology for drug delivery is a potential game changer for Alliqua. By using their transdermal platform to potentially deliver a variety of drugs, Alliqua can work with other pharmaceutical companies to deliver their drugs more effectively and in a less invasive way.

This delivery could eliminate the need for painful injections in certain drugs or expand markets for other drugs by making them easier to administer. This can lead to numerous potential pharmaceutical industry partnerships and multiple large revenue generating opportunities.

While it is very early in the game, if the company is successful in navigating through the development, partnering and regulatory process for delivering currently approved drugs through its transdermal platform, Alliqua could unlock a potential revenue opportunity in the hundreds of millions per year or higher. Alliqua is poised to move quickly in this direction.


http://www.mynewsletterbuilder.com/email/newsletter/1411531488

200MA@ $.051/ BMAK put up 5 mil on the bid Friday @ $.051???? (weird)
Golden Cross@ $.051 Coming Soon......

Wasn't the close we all wanted, but overall not a bad day...
Puffadder is right. Let's see what next week brings. Too much potential to be stuck down here.

GO ALQA~
$$$$$$$$$$$$$$$$$$

Volume is picking up some. Should have a nice close~

Another form 4 filed 11/29

Don't like that one

ALQA looking good

Absolutely Kaiser.... And people will have to check into Kaiser when they see ALQA CLIMB UP HUUUUGE!!!!!!
and did not buy at these levels. Yes...

.05's gone?...ALQA$$$$$$$$

$ALQA 100k on the bid at .06

$ALQA YES.... PLUS THERE IS A "NASTY" GOLDEN CROSS COMING!!!!!

$ALQA .07 close today?

.064 on the ask

WHAT PENNYSTOCK MANAGEMENT TEAM CAN COMPETE WITH ALQA?

The answer is NONE~

BIG THINGS COMING!!!!!!!!!!

EXPECT IT~

ALQA$$$$$$$$$$$$$$$$$$

No Wait... JOSEPH LAUDANO VP OF MEDICAL AFFAIRS, HE'S IN CHARGE!!!!!!!!

Who is he?.....

Why is he here?........

Hmmmmmmmmmm
$$$$$$$$$$$$ALQA~

Oh wait... JAMES SAPIRSTEIN IS IN CHARGE!!!!!!

Who is he?......

Why is he here?.....


Hmmmmmmmm....

JEROME ZELDIS IS IN CHARGE!!!!!!!!
Who is he? ....
Why is he here?

Hmmmmmmm.......

ALQA$$$$$$$$$$$$

$$$$ALQA......All the wheels are on the bus now....
TIME TO ROLL$$$$$$$$$$$$$

ALQA~

ALQA Close up +16%... Moving forward, this should get even more
interesting~

ALQA~

Nice~ Me Likey

$ALQA set up is NICE!!!!
Should be getting there soon~ .09+ will look very good